Correlation Between SAB Biotherapeutics and Alpha Cognition

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Alpha Cognition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Alpha Cognition into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and Alpha Cognition, you can compare the effects of market volatilities on SAB Biotherapeutics and Alpha Cognition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Alpha Cognition. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Alpha Cognition.

Diversification Opportunities for SAB Biotherapeutics and Alpha Cognition

-0.39
  Correlation Coefficient

Very good diversification

The 3 months correlation between SAB and Alpha is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Alpha Cognition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alpha Cognition and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Alpha Cognition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alpha Cognition has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Alpha Cognition go up and down completely randomly.

Pair Corralation between SAB Biotherapeutics and Alpha Cognition

Given the investment horizon of 90 days SAB Biotherapeutics is expected to under-perform the Alpha Cognition. But the stock apears to be less risky and, when comparing its historical volatility, SAB Biotherapeutics is 9.0 times less risky than Alpha Cognition. The stock trades about -0.02 of its potential returns per unit of risk. The Alpha Cognition is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  1,024  in Alpha Cognition on August 31, 2024 and sell it today you would lose (357.00) from holding Alpha Cognition or give up 34.86% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

SAB Biotherapeutics  vs.  Alpha Cognition

 Performance 
       Timeline  
SAB Biotherapeutics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in SAB Biotherapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak fundamental drivers, SAB Biotherapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
Alpha Cognition 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Alpha Cognition are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly conflicting technical and fundamental indicators, Alpha Cognition reported solid returns over the last few months and may actually be approaching a breakup point.

SAB Biotherapeutics and Alpha Cognition Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SAB Biotherapeutics and Alpha Cognition

The main advantage of trading using opposite SAB Biotherapeutics and Alpha Cognition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Alpha Cognition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alpha Cognition will offset losses from the drop in Alpha Cognition's long position.
The idea behind SAB Biotherapeutics and Alpha Cognition pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Commodity Directory
Find actively traded commodities issued by global exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements